Task: Answer the multiple choice question.
Query: Which drug exhibits a 1.585\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCc1cc2c(cc3c(=O)n(CC(=O)N4CCN(C)CC4)ncn32)s1
b: N#CCc1nn(-c2ccccc2)c2ncnc(N)c12
Answer: a. CCc1cc2c(cc3c(=O)n(CC(=O)N4CCN(C)CC4)ncn32)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1cc2c(cc3c(=O)n(CC(=O)N4CCN(C)CC4)ncn32)s1
CCc1cc2c(cc3c(=O)n(CC(=O)N4CCN(C)CC4)ncn32)s1
4-ethyl-10-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-5-thia-1,10,11-triazatricyclo[6.4.0.02,6]dodeca-2(6),3,7,11-tetraen-9-one